Angiogenesis in non-small cell lung cancer--clinical implications
Porebska, I.; Jankowska, R.
Pneumonologia i Alergologia Polska 69(5-6): 311-317
2001
ISSN/ISBN: 0867-7077 PMID: 11732294 Document Number: 538518
Document emailed within 1 workday
Related Documents
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70Inda, A.M.; Andrini, L.B.; García, M.N.; García, A.L.; Fernández Blanco, A.; Furnus, C.C.; Galletti, S.M.; Prat, G.D.; Errecalde, A.L. 2007: Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer Journal of Experimental and Clinical Cancer Research: Cr 26(3): 375-378
Rubio, L.; Vera-Sempere, F.J.; Lopez-Guerrero, J.A.; Padilla, J.; Moreno-Baylach, M.J. 2005: A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression Anticancer Research 25(1b): 497-504
Lind, J.S.W.; Herder, G.J.M.; Smit, E.F. 2008: New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis Nederlands Tijdschrift Voor Geneeskunde 152(16): 928-932
Hirai, F. 2015: III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
Giatromanolaki, A.; Koukourakis, M.I.; Kakolyris, S.; Kaklamanis, L.; Barbatis, K.; O'Byrne, K.J.; Theodosssiou, D.; Harris, A.L.; Gatter, K.C. 1998: Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer Anticancer Research 18(1a): 71-76
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Leonard, R.C.; Hay, F.G. 1989: Observations on the immunology of small cell lung cancer with implications for future management Pneumonologia Polska 57(10-12): 457-459
Sasaki, T.; Tanno, S.; Shibukawa, K.; Osanai, S.; Kawabe, J.; Ohsaki, Y. 2008: Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts International Journal of Oncology 33(3): 525-532
Mitsudomi, T.; Oyama, T.; Gazdar, A.F.; Minna, J.D.; Okabayashi, K.; Shirakusa, T. 1992: Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance Nihon Geka Gakkai Zasshi 93(9): 944-947
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Zhang, R.; Li, Y.; Chen, Y.; Liu, X.; Wang, Z.; Sun, H.; Zheng, Y.; Ding, Z.; Lan, L.; Li, M.; Qin, J.; Chen, X. 2015: Clinical implications of the concentration and EGFR/KRAS mutations of plasma cell free DNA of patients with lung cancer and esophageal cancer Zhonghua Yi Xue Za Zhi 95(47): 3839-3842
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Thammakumpee, K. 2004: Clinical manifestation and survival of patients with non-small cell lung cancer Journal of the Medical Association of Thailand 87(5): 503-507
Wang, J.; Liu, X.; Jiang, W. 2000: Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance Zhonghua Zhong Liu Za Zhi 22(4): 304-307
Argiris, A.; Murren, J.R. 2001: Staging and clinical prognostic factors for small-cell lung cancer Cancer Journal 7(5): 437-447
Cheson, B.D.; Phillips, P.H.; Feigal, E.G. 1994: Clinical trials referral resource. Non-small-cell lung cancer Oncology 8(2): 56; 61, 65
Thammakumpee, K.; Juthong, S.; Viriyachaiyo, V.; Rittirak, W.; Tanomkiat, W. 2007: Clinical manifestation and survival of patients with small-cell lung cancer Journal of the Medical Association of Thailand 90(7): 1303-1308
Niklinska, W.; Laudanski, J.; Niklinski, J. 2001: G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview Neoplasma 48(3): 157-163
Cheson, B.D. 1990: Clinical trials referral resource. NCI-Navy: small cell lung cancer Oncology 4(9): 129-130